CGS vs IMM

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

58MEDIUM

IMM

IMMUTEP FPO [IMM]

63MEDIUM-HIGH

Score Breakdown

CGS IMM
Technical
47
69
Catalyst
53
71
Sentiment
50
50
Fundamental
96
93
Momentum
79
42
Risk Gate
50
50

Key Metrics

CGS Metric IMM
$489.3MMarket Cap$81.1M
397KAvg Volume (20d)14.6M
+0.1%Short Interest+2.4%
$3.01052-Week High$0.470
$1.55052-Week Low$0.028
-3.5%Daily Change-1.8%
$2.780Reference Price$0.055
+22.5%ROE-61.8%
+19.2%Profit MarginN/A

Active Signals

CGS Signals

●MACD crossed bearish — momentum is fading
●Volume surging at 2.4x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.7x)
●Moderate revenue growth (+12%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

IMM Signals

●MACD momentum is picking up steam
●Trading above both moving averages — the trend is your friend here
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (6 quarters)
●Moderate P/S ratio (10.2x)
●Strong revenue growth (+92%)

Ask Scout AI to compare CGS and IMM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CGS vs LDX →CGS vs NTI →CGS vs NYR →CMP vs EMD →CMP vs EPN →
CGS Full Analysis → IMM Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).